Cipla Achieves 100% GMP Documentation Compliance with Mobile Quality Software

Cipla Limited, a global pharmaceutical company with operations in 86 countries, faced a recurring challenge in its manufacturing facilities: GMP compliance teams were relying on paper-based processes and generic mobile apps to capture and document compliance observations. Without a structured, regulated system, photos lacked proper audit trails, metadata, and approval workflows — creating potential risks during regulatory inspections.

AmpleLogic's Secure Snap platform was deployed to address this gap. The solution provided Cipla's quality teams with a dedicated mobile app for capturing GMP compliance photographs directly linked to deviation records, CAPA workflows, and inspection checklists. Every photo was automatically timestamped, geo-tagged, and linked to the relevant GMP activity, ensuring complete traceability from observation to closure.

The rollout spanned multiple Indian manufacturing sites, with role-based access ensuring that only authorized personnel could capture, review, and approve compliance documentation. Integration with Cipla's existing quality management system enabled seamless data flow, eliminating the need to manually transfer images or re-enter context information.

The result was a dramatic improvement in GMP documentation quality and compliance readiness. Inspectors noted the comprehensive, tamper-evident photo records during audits, and the quality team reported significant reductions in documentation-related observations. Cipla achieved 100% mobile GMP documentation compliance across all deployed sites, setting a new standard for visual compliance management in pharmaceutical manufacturing.